tezspire
astrazeneca ab - tezepelumab - asma - medicamentos para la enfermedad obstructiva de las vías respiratorias enfermedades, - tezspire is indicated as an add-on maintenance treatment in adults and adolescents 12 years and older with severe asthma who are inadequately controlled despite high dose inhaled corticosteroids plus another medicinal product for maintenance treatment.
tezspire® 210 mg/ 1.91 ml solucion inyectable
astrazeneca peru s.a. - droguerÍa - solucion inyectable - por jeringa precargada 1.91 ml - - tezepelumab
gamifant
swedish orphan biovitrum ab (publ) - emapalumab - immune system diseases - gamifant is indicated for the treatment of paediatric patients aged under 18 years with primary haemophagocytic lymphohistiocytosis (hlh).
sigtiphin 200 mg comprimidos recubiertos
meyer productos terapeuticos, s.a. - flavoxate - comprimido - 200 mg